September 1, 2016
A think tank arm of the Japan Medical Association (JMA) has penned a working paper on drug price-setting, calling for subsidies aimed at supporting pharma companies’ drug development, instead of rewarding their innovation through reimbursement prices. While proposing the idea,...read more